Voltage-Dependent Potassium Channels Kv1.3 and Kv1.5 in Human Cancer
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
904-914
Author(s):
J. Bielanska, J. Hernandez-Losa, M. Perez-Verdaguer, T. Moline, R. Somoza, S. Ramon y Cajal, E. Condom, J. C. Ferreres and A. Felipe
Antibody-Drug Conjugate Targets
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
982-1004
Author(s):
B. A. Teicher
The Use of Statins in Hematopoietic Stem Cell Transplantation
Journal:
Current Stem Cell Research & Therapy
Volume:
4
Page:
260-265
Author(s):
Alexander Shimabukuro-Vornhagen, Jan Glossmann, Tanja Liebig, Christof Scheid and Michael von Bergwelt-Baildon
Structure, Function and Inhibition of Bcl-2 Family Proteins: A New Target for Anti-Tumor Agents
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
9
Page:
1596-1604
Author(s):
Guizhi Xiao, Hao Fang, Chengguo Xing and Wenfang Xu
Economic and Cost-Effectiveness Considerations for Pharmacogenetics Tests: An Integral Part of Translational Research and Innovation Uptake in Personalized Medicine
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
7
Page:
284-296
Author(s):
D. Paci and D. Ibarreta
Molecular Imaging of Apoptosis In Vivo with Scintigraphic and Optical Biomarkers – A Status Report
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
968-985
Author(s):
Andreas Faust, Sven Hermann, Stefan Wagner, Gunther Haufe, Otmar Schober, Michael Schafers and Klaus Kopka
Reduced Nicotinamide Adenine Dinucleotide (NADH) Fluorescence for the Detection of Cell Death
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
1012-1017
Author(s):
Hsing-Wen Wang, Yau-Huei Wei and Han-Wen Guo
Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
1024-1038
Author(s):
Kiyotaka Kawauchi, Toshie Ogasawara, Masako Yasuyama, Kuniaki Otsuka and Osamu Yamada
The Combination of Conventional Chemotherapy with New Targeted Therapy in Hematologic Malignancies: The Safety and Efficiency of Low- Dose Cytarabine Supports its Combination with New Therapeutic Agents in Early Clinical Trials
Journal:
Current Cancer Therapy Reviews
Volume:
5
Page:
243-255
Author(s):
Hanne Fredly, Elisabeth Ersvaer, Camilla Stapnes, Bjorn Tore Gjertsen and Oystein Bruserud
Targeting Toll-like Receptors in Autoimmunity
Journal:
Current Drug Targets
Volume:
10
Page:
1139-1155
Author(s):
K. S. Midwood, A. M. Piccinini and S. Sacre